pressure-treated astrocytes were also subjected to thapsigargin (50-250 nm) treatment, but it is unclear whether this had any further effect in increasing pad2 expression.
Treatment with calcium chelating agent BAPTA-AM (50-250 nM) results in decreased intracellular calcium concentration and PAD2.